Bio-Techne Advances Spatial Biology with Modular Expansion of COMET™ Suite

Rhea-AI Summary

Bio-Techne (NASDAQ: TECH) on March 25, 2026 expanded its COMET spatial biology portfolio with new SPYRE Focus Panels (Stroma and Vessel) and SPYRE Amplification Kits. These add modular panel options, seqLA amplification for low-abundance targets, and HORIZON image-analysis enhancements to streamline hyperplex tissue workflows.

The release emphasizes increased sensitivity, faster setup, and flexibility for integrating lab antibodies across the COMET automated ecosystem to support research and preclinical studies.

Key Figures

Performance RSUs grant: 2,387 units Restricted stock units: 735 units Stock options grant: 1,911 options +5 more

8 metrics

Performance RSUs grant 2,387 units Form 4, March 2, 2026 grant to Steven C. Crouse

Restricted stock units 735 units Form 4, March 2, 2026 grant to Steven C. Crouse

Stock options grant 1,911 options Form 4, March 2, 2026 grant to Steven C. Crouse

Rule 144 planned sale 1,976 shares Rule 144 notice filed to sell TECH common stock

Rule 144 sale value $116,791.48 Aggregate market value for 1,976 shares in Rule 144 filing

Shares outstanding 156,453,292 shares Baseline common shares in Rule 144 filing

Executive base salary $505,000 Annual base salary for Steve Crouse per 8-K

Target bonus rate 75% of base pay Target annual cash bonus for Steve Crouse

Market Reality Check

Price: $52.43 Vol: Volume 1,814,375 is at 76...

normal vol

$52.43 Last Close

Volume Volume 1,814,375 is at 76% of the 20-day average, suggesting no outsized positioning ahead of this release. normal

Technical Shares at $52.43 are trading below the 200-day MA of $57.65, and about 27% under the 52-week high of $72.16.

Peers on Argus

TECH gained 0.83% while peers were mixed: JAZZ +1.78%, BPMC +0.09%, VRNA +0.06%,...

TECH gained 0.83% while peers were mixed: JAZZ +1.78%, BPMC +0.09%, VRNA +0.06%, versus HALO -0.56% and RVMD -0.67%, pointing to company-specific factors.

Historical Context

5 past events · Latest: Feb 24 (Neutral)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Feb 24	Investor conferences	Neutral	+5.2%	Company scheduled presentations at two early March 2026 healthcare investor conferences.
Feb 16	Regulatory clearance	Positive	-2.4%	Ella immunoassay platform received CE‑IVD marking, expanding EU clinical use.
Feb 11	Leadership change	Neutral	-2.1%	Diagnostics and Spatial Biology leadership transition to Steve Crouse effective March 1, 2026.
Feb 04	Dividend declaration	Positive	+6.3%	Announced $0.08 quarterly cash dividend and highlighted >$1.2B FY2025 net sales.
Feb 04	Earnings release	Positive	+6.3%	Reported flat revenue but higher EPS and margins for Q2 FY26 with stronger profits.

Pattern Detected

Recent positive operational and capital return updates often saw supportive price reactions, while some regulatory/leadership news drew softer or negative moves.

Recent Company History

Over the last two months, Bio-Techne reported Q2 FY26 results with revenue of $295.9 million and stronger margins, alongside a quarterly dividend of $0.08 per share; both coincided with a 6.25% gain. Regulatory filings highlighted essentially flat sales but better profitability and cash flow. A CE-IVD mark for the Ella platform and leadership changes in Diagnostics and Spatial Biology drew modest negative reactions. Today’s product-focused spatial biology update extends this pattern of incremental platform and portfolio enhancements.

Market Pulse Summary

This announcement extends Bio-Techne’s spatial biology strategy by adding SPYRE Focus Panels, SPYRE ...

Analysis

This announcement extends Bio-Techne’s spatial biology strategy by adding SPYRE Focus Panels, SPYRE Amplification Kits using seqLA technology, and HORIZON software enhancements to the COMET ecosystem. Recent history included Q2 FY26 results with $295.9 million in revenue, a $0.08 dividend, and regulatory filings detailing executive equity awards and modest insider sales. Investors may watch how these new tools influence consumables usage within Diagnostics and Spatial Biology and compare traction with earlier platform wins like the CE‑IVD‑approved Ella system.

Key Terms

spatial biology, multiplex

2 terms

spatial biology medical

"enabling deeper targeted insights in spatial biology workflows."

Spatial biology maps where different cells and molecules sit inside tissues, like a detailed city map showing not just who lives in a neighborhood but where every house and shop is located. For investors, those location details can reveal how diseases start and respond to treatments, guiding new drugs, diagnostics, and lab tools that can change clinical success rates and create commercial opportunities.

multiplex medical

"modular antibody panels designed to enable flexible multiplex assay design"

A multiplex is a laboratory test or diagnostic method that detects or measures several different targets at the same time from a single sample, like checking for multiple ingredients in one recipe rather than cooking separate dishes. For investors, multiplex technologies can lower testing costs, speed results, and expand market reach because one product can serve multiple purposes, affecting revenue potential, production scale, and regulatory review paths.

AI-generated analysis. Not financial advice.

• New SPYRE™ Focus Panels (Stroma and Vessel) broaden modular panel options, enabling deeper targeted insights in spatial biology workflows. 
  
  
• SPYRE™ Amplification Kits leverage sequential and enhanced layered amplification (seqLA™) technology enabling improved detection of low-abundance and challenging targets. 
  
  
• Enhancements strengthen the fully integrated COMET spatial biology ecosystem, supporting increased consumables adoption and panel expansion.

MINNEAPOLIS, March 25, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a global provider of life science tools, reagents and diagnostic products, today announced the expansion of its COMET™ solution portfolio with the addition of the new SPYRE™ Focus Panels and SPYRE™ Amplification Kits. Together, these strengthen the COMET technology modular, automated spatial biology workflow, delivering expanded flexibility, greater sensitivity, and enabling deeper, more focused interrogation of biologically meaningful data from initial assay design through final interpretation. To support these updates, new features of HORIZON™ Image Analysis Software have also been introduced, tailored for COMET hyperplex images using the new SPYRE tools, further streamlining tissue analysis.

"Researchers need tools that make it easier to extract meaningful answers from complex tissue samples," said Steve Crouse, President of Bio-Techne's Diagnostics and Spatial Biology Segment. "Innovation is one of Bio-Techne's key differentiators, and SPYRE Focus Panels and SPYRE Amplification Kits reflect that strength. By incorporating these capabilities into the COMET Suite, we are giving researchers a more flexible, faster, and higher sensitivity workflow that enables researchers to achieve deeper insights with greater confidence."

SPYRE™ Antibody Panels, including the newly introduced Stroma and Vessel Focused Panels, are modular antibody panels designed to enable flexible multiplex assay design while reducing optimization time. Panels leverage validated antibodies with ready-to-use protocols to streamline setup while maintaining flexibility to incorporate markers from a lab's own antibody library. SPYRE™ Amplification Kits use seqLA™ technology to improve the detection of low‑abundance and difficult‑to‑detect targets.

"Utilizing the pre-optimized SPYRE panel has not only increased the capacity of conventional multiplex immunofluorescence but also enabled a one-day experimental protocol," said Prof. Joanne Edwards, Professor of Translational Cancer Pathology, University of Glasgow. "The COMET workflow is straightforward and flexible, allowing us to easily integrate our own antibodies of interest. This technology provides insightful data, facilitating the simultaneous investigation of tumor and microenvironment cells within the same sample."

Together, SPYRE Focus Panels and SPYRE Amplification Kits strengthen Bio-Techne's commitment to deliver a fully integrated, modular, and automated spatial biology ecosystem that accelerates research and preclinical therapeutic development. These innovations continue to empower researchers to generate richer data and deeper biological understanding from every tissue sample.

ABOUT BIO-TECHNE: 
Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With hundreds of thousands of products in its portfolio, Bio-Techne generated over $1.2 billion in net sales in fiscal 2025 and has approximately 3,100 employees worldwide. For more information, visit www.bio-techne.com or follow the Company on social media at LinkedIn, X and YouTube.

MEDIA CONTACTS: 

Corporate Communications 
media.relations@bio-techne.com

David Clair, Vice President Investor Relations
ir@bio-techne.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/bio-techne-advances-spatial-biology-with-modular-expansion-of-comet-suite-302724287.html

SOURCE Bio-Techne Corporation

FAQ

What did Bio-Techne (TECH) announce on March 25, 2026 about COMET spatial biology?

Bio-Techne announced new SPYRE Focus Panels and SPYRE Amplification Kits for COMET workflows. According to the company, these add Stroma and Vessel panels, seqLA amplification for low-abundance targets, and HORIZON software updates to streamline hyperplex image analysis.

How do SPYRE Amplification Kits improve detection on COMET (TECH)?

SPYRE Amplification Kits use seqLA layered amplification to boost signal for low-abundance targets. According to the company, seqLA enables improved detection of challenging markers, increasing sensitivity within the COMET automated spatial biology workflow.

What do SPYRE Focus Panels (Stroma and Vessel) mean for lab workflows using TECH COMET?

SPYRE Focus Panels provide modular, pre-validated antibody panels for targeted tissue profiling. According to the company, they reduce optimization time, enable flexible multiplex design, and allow labs to add their own antibodies into the COMET workflow.

Will HORIZON software changes affect COMET image analysis for TECH customers?

Yes. HORIZON updates are tailored for COMET hyperplex images using SPYRE tools to streamline tissue analysis. According to the company, the software enhancements improve interpretation and workflow integration from assay design to final data review.

How might the SPYRE additions affect preclinical research timelines for TECH users?

The SPYRE additions aim to speed experimental workflows by reducing optimization and enabling faster protocols. According to the company, pre-optimized panels and amplification kits can shorten assay setup and support one-day experimental protocols in some labs.